<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">73926</article-id><article-id pub-id-type="doi">10.7554/eLife.73926</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Advance</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>Reversing chemorefraction in colorectal cancer cells by controlling mucin secretion</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-225700"><name><surname>Cantero-Recasens</surname><given-names>Gerard</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6452-782X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-253588"><name><surname>Alonso-Marañón</surname><given-names>Josune</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-253589"><name><surname>Lobo-Jarne</surname><given-names>Teresa</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-253590"><name><surname>Garrido</surname><given-names>Marta</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-253591"><name><surname>Iglesias</surname><given-names>Mar</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-181336"><name><surname>Espinosa</surname><given-names>Lluis</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2897-4099</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-1133"><name><surname>Malhotra</surname><given-names>Vivek</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6198-7943</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="corresp" rid="cor3">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><institution content-type="dept">Renal Physiopathology Group</institution>, <institution>Vall d'Hebron Institut de Recerca</institution>, <addr-line><named-content content-type="city">Barcelona</named-content></addr-line>, <country>Spain</country></aff><aff id="aff2"><institution content-type="dept">Cancer Research Program</institution>, <institution>Institut Mar d'Investigacions Mèdiques</institution>, <addr-line><named-content content-type="city">Barcelona</named-content></addr-line>, <country>Spain</country></aff><aff id="aff3"><institution content-type="dept">Department of Pathology</institution>, <institution>Institut Mar d'Investigacions Mèdiques</institution>, <addr-line><named-content content-type="city">Barcelona</named-content></addr-line>, <country>Spain</country></aff><aff id="aff4"><institution content-type="dept">Centre for Genomic Regulation</institution>, <institution>The Barcelona Institute of Science and Technology</institution>, <addr-line><named-content content-type="city">Barcelona</named-content></addr-line>, <country>Spain</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-86926"><name><surname>Ten Hagen</surname><given-names>Kelly G</given-names></name><role>Reviewing editor</role><aff><institution>National Institutes of Health</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>gerard.cantero@vhir.org</email> (GC);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>lespinosa@imim.es</email> (LE);</corresp><corresp id="cor3"><label>*</label>For correspondence: <email>vivek.malhotra@crg.eu</email> (VM);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>08</day><month>02</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e73926</elocation-id><history><date date-type="received"><day>17</day><month>09</month><year>2021</year></date><date date-type="accepted"><day>04</day><month>02</month><year>2022</year></date></history><permissions><copyright-statement>© 2022, Cantero-Recasens et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Cantero-Recasens et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-73926-v1.pdf"/><abstract><p>15% of colorectal cancers (CRC) cells exhibit a mucin hypersecretory phenotype, which is suggested to provide resistance to immune surveillance and chemotherapy. We now formally show that colorectal cancer cells build a barrier to chemotherapeutics by increasing mucins' secretion. We show that low levels of KChIP3, a negative regulator of mucin secretion (Cantero-Recasens <italic>et al.</italic>, 2018), is a risk factor for CRC patients' relapse in subset of untreated tumours. Our results also reveal that cells depleted of KChIP3 are four times more resistant (measured as cell viability and DNA damage) to chemotherapeutics 5-Fluorouracil plus Irinotecan (5-FU+iri.) compared to control cells, whereas KChIP3 overexpressing cells are 10 times more sensitive to killing by chemotherapeutics. Similar increase in tumour cell death is observed upon chemical inhibition of mucin secretion by the sodium/calcium exchanger (NCX) blockers (Mitrovic <italic>et al.</italic>, 2013). Finally, sensitivity of CRC patient-derived organoids to 5-FU+iri increases 40-fold upon mucin secretion inhibition. Reducing mucin secretion thus provides a means to control chemoresistance of mucinous colorectal cancer cells and other mucinous tumours.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100010198</institution-id><institution>Ministerio de Economía, Industria y Competitividad, Gobierno de España</institution></institution-wrap></funding-source><award-id>BFU2013-44188-P</award-id><principal-award-recipient><name><surname>Malhotra</surname><given-names>Vivek</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004587</institution-id><institution>Instituto de Salud Carlos III</institution></institution-wrap></funding-source><award-id>PI19-00013</award-id><principal-award-recipient><name><surname>Espinosa</surname><given-names>Lluis</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Vivek Malhotra, Senior editor, <italic>eLife</italic>.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed are included in the manuscript</p><p>The following previously published datasets were used:</p><p><element-citation id="dataset1" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Jorissen</collab><collab>R. N.</collab><collab>Gibbs</collab><collab>P.</collab><collab>Christie</collab><collab>M.</collab><collab>Prakash</collab><collab>S.</collab><collab>Lipton</collab><collab>L.</collab><collab>Desai</collab><collab>J.</collab><collab>Kerr</collab><collab>D.</collab><collab>Aaltonen</collab><collab>L. A.</collab><collab>Arango</collab><collab>D.</collab><collab>Kruhøffer</collab><collab>M.</collab><collab>Orntoft</collab><collab>T. F.</collab><collab>Andersen</collab><collab>C. L.</collab><collab>Gruidl</collab><collab>M.</collab><collab>Kamath</collab><collab>V. P.</collab><collab>Eschrich</collab><collab>S.</collab><collab>Yeatman</collab><collab>T. J.</collab><collab>and Sieber</collab><collab>O. M.</collab></person-group><year iso-8601-date="2009">2009</year><source>Jorissen Cohort</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE14333">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE14333</ext-link><comment>GSE14333</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-73926-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>